This measurable deficit provides objective, biochemical proof of the mitochondrial dysfunction that patients experience, validating their symptoms and highlighting the carnitine shuttle as a primary target for therapeutic intervention
Cost has emerged as another major hurdle, with monthly treatment expenses typically ranging between USD 1,000 and USD 1,400 without insurance coverage
Gastrointestinal symptoms are the most common, especially during dose initiation or increases
Cytokines in inflammatory disease
If you have started a weight loss or metabolic health journey, you might worry that your treatment could disqualify you from this act of service
This creates a significant access gap, especially considering that studies have shown most patients regain the lost weight if treatment is discontinued highlighting the potential need for lifelong use